Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Roivant Sciences Ltd.

Pharmaceutical Preparations · London

  1. PrincipalsEric VenkerPresident & Immunovant CEOFrank TortiPresident and Vant ChairJennifer HumesChief Accounting Officerand 9 more
  2. CompanyRoivant Sciences Ltd.London
  3. Phone line+1 441 295 5950General business
Request a quote

Roivant Sciences Ltd. is an SEC-registered Nasdaq-listed company (ticker ROIV) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 12

Chief executive

Eric VenkerPresident & Immunovant CEO
Frank TortiPresident and Vant Chair
Mayukh SukhatmePresident & CIO

Chair & board

Daniel Allen GoldDirector (Board)
Ilan OrenDirector (Board)
James C MomtazeeDirector (Board)
Keith S ManchesterDirector (Board)

Finance

Jennifer HumesChief Accounting Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Jennifer Humes — Chief Accounting Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Eric Venker — President & Immunovant CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Frank Torti — President and Vant Chair

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers